Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263387
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-12-14
Brief Title:
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia AML Patients Ineligible for Intensive Chemotherapy IC Treated With Venetoclax Azacitidine
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Organization Data
Organization:
French Innovative Leukemia Organisation
Class:
OTHER
Study ID:
FILObsLAM_VENAZA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French Innovative Leukemia Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Acute Leukemia French Association | OTHER |